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Mouse hepatitis virus (MHV) utilizes the murine biliary glycoprotein receptor (BgpA) for entry into susceptible cells. The
Bgp1a gene was transfected into a murine DBT cell clone that expressed little if any BgpA receptor and resisted wild-type
MHV infection. Clones which expressed low levels of receptor were efficient hosts for MHV-A59 replication. Clones which
expressed 20- to 69-fold more BgpA receptor than controls were also susceptible to MHV-A59 infection, yet few infectious
progeny virions were released. Pretreatment of clones with monoclonal antibody CC1, which binds to the N-terminus of
BgpA, blocked MHV-A59 replication in DBT clones that expressed wild-type levels of receptor protein. In the overexpressing
cell clones, however, CC1 pretreatment reversed the BgpA overexpression blockade and increased virus titers by 3–4 logs.
BgpA overexpression inhibited the formation of infectious extracellular and intracellular virions, but levels of virus transcrip-
tion were equivalent to those of controls. Ultrastructural studies revealed normal cell cytopathology in both the MHV-A59-
infected controls and the overexpressing cell clones. Although equivalent numbers of virions were released compared with
the control, peplomer spike glycoproteins were rarely evident in virions derived from the BgpA-overexpressing cell clones.
Consonant with these findings, purified virions from BgpA-overexpressing cell clones demonstrated a 70% reduction in the
amount of S glycoprotein, but not of N or M proteins. These data suggest that BgpA receptor overexpression establishes
an intracellular trap which blocks MHV replication during the maturation and release of infectious progeny virions. q 1997
Academic Press
INTRODUCTION 1996). Overexpression of the CD4 cellular receptor for
entry has also proven effective at blocking HIV replication
Intracellular immunization using genes that confer a
in vitro (Buonocore and Rose, 1990, 1993; Weber, 1990).dominant negative phenotype represents a reasonable
Mouse hepatitis virus (MHV), a member of Coronaviri-approach to abrogate the pathogenic potential of viruses
dae, contains a single-stranded positive polarity RNA ge-(Baltimore, 1988; Friedman et al., 1988). In pathogen-
nome (Pachuk et al., 1989). The genomic RNA is sur-derived resistance, expression of some viral structural
rounded by a 50-kDa nucleocapsid protein (N) and a lipidor nonstructural genes confers resistance to infection
bilayer which contains three or four membrane glycopro-with homologous plant viruses in transgenic plants
teins (Lai, 1992; Sturman and Holmes, 1985). The 180/90(Fitchen and Beachy, 1993; Graves et al., 1996; Olson et
kDa S glycoprotein functions in attachment and entry intoal., 1996). Alternatively, approaches using virus-specific
susceptible hosts and encodes determinants for MHV-ribozymes, antisense RNAs, or selective killing of virus-
induced fusion, tissue tropism, and pathogenesis (Dvek-infected cells may also enhance intracellular resistance
sler et al., 1991, 1993a; Kubo et al., 1994). While the 23-to virus infection in vitro (Sarver et al., 1990; Shaheen et
kDa M glycoprotein directs virus maturation into intracel-al., 1996). Although few examples exist, virus replication
lular membranes (Griffiths and Rottier, 1992; Locker etand pathogenesis may be inhibited by overexpression of
al., 1992), the 10.5-kDa small membrane (E) glycoproteincellular genes which disrupt critical sites of virus–host
functions in M secretion and virus budding (Yu et al.,interaction—a concept referred to as host-derived resis-
1995; Vennema et al., 1996).tance (Weber, 1990). Expression of the murine BclII onco-
MHV entry into susceptible cells is governed by spe-gene significantly reduced Sindbis virus-induced en-
cific interactions between MHV S glycoprotein and thecephalitis and death in mice and reduced virus replica-
cellular receptor (MHVR) (Dveksler et al., 1991; Williamstion and cytopathic effects in vitro (Levine et al., 1993,
et al., 1990). MHVR is a 110-kDa member of the biliary
glycoprotein (Bgp) subgroup of the carcinoembryonic an-
1 To whom correspondence and reprint requests should be ad- tigen (CEA)-related glycoprotein family (Chen et al., 1995;dressed at Department of Epidemiology, University of North Carolina
McCuaig et al., 1993; Nedellec et al., 1994). Two Bgpat Chapel Hill, Chapel Hill, NC 27599-7400. Fax: (919) 966-2089. E-mail:
RBaric@SPHVAX.SPH.UNC.EDU. genes (Bgp1 and Bgp2) have been characterized in the
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mouse. Two polymorphic alleles, Bgp1a and Bgp1b, of tional second-antibody indirect-staining method ac-
cording to the procedures provided by the manufacturerthe Bgp1 gene are expressed as numerous isoforms by
alternative splicing and can serve as receptors for MHV (Becton Dickinson Immunocytometry Systems, San Jose,
CA). Briefly, 106 cells were harvested by trypsinization,(Dveksler et al., 1993a; Yokomori and Lai, 1992). BgpA,
formerly designated mmCGM1 or MHVR1, is one of the resuspended in PBS, and incubated on ice for 45 min
with a 1:5 dilution of monoclonal antibody (mAB) CC1Bgp1a gene products expressed in susceptible mice
(Dveksler et al., 1991). The N-terminal domain of BgpA (kindly provided by Dr. Kathryn V. Holmes, University of
Colorado Health Sciences Center) which recognized thepresumably interacts with the S1 domain of the S glyco-
protein to initiate entry (Dveksler et al., 1995; Kubo et al., N-terminal domain of BgpA (Dveksler et al., 1993; Wil-
liams et al., 1990). Cells were washed twice with ice-1994).
In this paper, we have isolated cloned cell lines in vitro cold PBS and incubated with a 1:30 dilution of sheep
anti-mouse IgG R-Phycoerythrin conjugate (Sigma) for 45that express low and high levels of the BgpA receptor.
Overexpression of receptor did not block virus replication min on ice. Following two washes with ice-cold PBS,
cells were resuspended at a concentration of 2 1 106or cytopathic effects, but resulted in the release of nonin-
fectious particles containing little S glycoprotein. Thus, cells/ml in 0.5 ml and analyzed with a FACScan equipped
with CICERO Interface and IBM-based Cyclops Softwareoverexpression of BgpA confers a dominant negative
phenotype on MHV infection, suggesting that gene ther- (Becton Dickinson Immunocytometry Systems).
apy using receptors for entry may offer a reasonable
Growth curves and detection of viral intracellular RNAapproach to rescind the pathogenic potential of viruses.
Individual cell clones were seeded at densities of 2 1MATERIALS AND METHODS
105 cells per well in 24-well plates and infected with
Cells and viruses MHV-A59 or different variant viruses at a multiplicity of
infection (m.o.i.) of 5 for 1 hr at room temperature. TheThe DBT 9 cells were cloned from our laboratory stock
inoculum was removed, the monolayers were washedof DBT cells (Chen and Baric, 1996). The PDBT-5 cell
twice with phosphate-buffered saline (PBS), and thenclone, which was isolated from MHV-A59 persistently
fresh medium was added to the cultures. Samples ofinfected cultures of DBT cells at 30 days postinfection,
virus were harvested at different times postinfection.had spontaneously cured MHV infection (Chen and Baric,
After removal of the medium, the cells were washed 311996). DBT, DBT 9, and PDBT-5 cells were maintained
with 5 ml of ice-cold PBS and freeze–thawed at differentin Eagle’s minimum essential medium containing 7% fetal
times postinfection. The titer of intracellular virus wasclone II supplemented with 5% tryptose phosphate broth,
determined by plaque assay in DBT cells.0.05 mg/ml gentamicin, and 0.25 mg/ml kanamycin. The
Intracellular RNA was extracted at different times post-plasmid MHVR, containing the four-domain isoform of
infection using RNA-STAT 60 reagents (total RNA/mRNABgp1a under the control of the cytomegalovirus promoter
isolation reagent; Tel-TEST ‘‘B’’, INC., Friedwood, TX).in the pcDNA3 vector (Invitrogen), was kindly provided
Equivalent amounts of intracellular RNA were bound toby Kathryn V. Holmes (University of Colorado Health Sci-
nitrocellulose filters and then hybridized with a radiola-ences Center) and was transfected into PDBT-5 cells
beled 1.6-kb MHV-A59 N gene probe from the IBI 76N(Dveksler et al., 1991). PDBT-5 cell clones expressing
cDNA clone (Schaad et al., 1990). The 32P-radiolabeledthe MHV receptor (R-2, R-14, R-17, R-19, and R-24) were
DNA probe was synthesized using a random primer DNAisolated after 4 weeks of geneticin (G-418) (Sigma) selec-
labeling system (GIBCO, BRL). After the filters were ex-tion in complete Eagle’s minimum essential medium con-
posed to Kodak X-ray film, the dots were localized, ex-taining 800 mg/ml of G-418 (Chen and Baric, 1996).
cised, and counted.MHV-A59 was plaque purified and propagated in DBT
cells (Baric et al., 1990). Variant viruses were collected at
Detection of viral proteins by immunofluorescence119 days postinfection from MHV-A59 persistently infected
DBT cultures and plaque purified twice in DBT cells. Vari- Various cell clones grown on LabTek chamber slides
ants contained either the A-to-G mutation at the nucleotide (Nunc, Inc., Naperville, IL) were infected with MHV-A59.
(nt) 77 locus in the 5*-UTR (V16/) or were identical to The inoculum was removed, cells were washed twice
MHV-A59 (V10) (Chen and Baric, 1995). The TRSB strain with PBS, and complete medium was added to the cul-
of Sindbis virus was kindly provided by Robert E. Johnson, tures. At different times postinfection, cells were fixed
University of North Carolina at Chapel Hill. with acetone:methanol (1:1) and stored at 47. Fixed cells
were incubated with a 1:200 dilution of a mouse poly-
Detection of BgpA by FACs clonal antibody against MHV-A59 for 30 min at room
temperature. After three washes with PBS, the cells wereExpression of BgpA was assessed by fluorescence-
activated cell sorter (FACS) analysis using the conven- incubated with a 1:100 dilution of goat anti-mouse IgG-
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fluorescein isothiocyanate conjugate (Sigma) for 30 min pretreated with twofold serial dilutions of CC1 for 1 hr
prior to infection. After incubation, the antibodies wereat room temperature, washed with PBS, counterstained
with Evans blue (Sigma), and examined under a Nikon removed and the cells infected with MHV-A59 at an m.o.i.
of 5 for 1 hr. The virus inoculum was removed, the cul-FXA fluorescence microscope. Eight fields from each in-
fected cell clone were randomly chosen and analyzed by tures were washed twice with PBS to removed residual
virus, and 300 ml of complete medium was mixed withfluorescence density techniques. Levels of viral protein
expression in independent cell clones were quantitated the mAb CC1 dilution (100 ml) and added to the cultures.
Control monoclonal antibodies (EDDA) of the same iso-using the public domain NIH image program version 1.57
(available from the Internet by anonymous FTP from type directed against an irrelevant antigen (cholera toxin)
were also diluted 1:4 in these experiments (kindly pro-zippy.nimh.nih.gov).
vided by Dr. Kathryn V. Holmes, University of Colorado
Concentration of extracellular virions Health Sciences Center). Monoclonal antibody Col-1, di-
rected against the human CEA glycoprotein, was kindlyDBT 9 and R-17 cells were seeded at 5 1 106 cells per
provided by Dr. J. Schloam, NIH. Samples were harvested75-cm2 flask and infected with MHV-A59. After removal of
at different times postinfection and stored at 0707 forinoculum, monolayers were washed twice with PBS and
plaque assay in DBT cells.then fresh Eagle’s minimal essential medium containing
1% fetal calf serum was added to cultures. Extracellular Immunoprecipitation of virion polypeptides
virions were harvested at 18 hr postinfection and centri-
Radiolabeling and immunoprecipitation of virion poly-fuged at 10,000 g for 30 min at 47 to remove cellular
peptides were performed as previously described (Chendebris. The supernatants were collected and floated on
and Baric, 1995). Briefly, DBT 9 cells or BgpA-overex-a 20% sucrose cushion and virions were concentrated
pressing R-17 cells were infected with MHV-A59 in 75-by centrifugation at 92,500 g for 2 hr at 47. The pellets
cm2 flasks at an m.o.i. of 10. After the virus inocula werewere resuspended in 150 ml of TNE buffer (0.1 M NaCl,
removed, the cells were washed twice with PBS and10 mM Tris, 1 mM EDTA, pH 7.4) and the total number
incubated in methionine- and cysteine-free Eagle’s mini-of viral particles was determined by electron microscopy
mum essential medium containing 1% fetal calf serumusing negative stain.
and 500 mCi [35S]methionine–cysteine (Tran35S-label;
ICN) per flask at 377. Fifty milliliters of infected cultureElectron microscopy
medium was collected at 16 hr postinfection and concen-
Concentrated virion suspensions were examined us- trated by ultracentrifugation through a 20% sucrose cush-
ing the negative stain technique. A glow discharged, car- ion. The virus-containing fractions were resuspended in
bon-coated, pioloform-covered, 300-mesh nickel grid 500 ml of lysis solution (1% Nonidet-P40, 1% sodium deox-
was placed carbon side down onto a drop of virus sus- ycholate, 150 mM NaCl, 10 mM Tris, pH 7.4) containing
pension for 5 min and then stained in a drop of 1% aque- 0.1% of SDS, and incubated on ice for 30 min. The sus-
ous uranyl acetate (pH 3.5) for 1 min. After staining, the pension was then immunoprecipitated with a mouse
grids were air dried and examined at 60 kV in a Zeiss polyclonal antiserum directed against MHV-A59. Anti-
EM-10A transmission electron microscope (LEO Electron body (5 ml) was first bound to 40 ml of protein A–Sepha-
Microscopy, Inc., Thornwood, NY). Ten to 12 fields from rose beads (Sigma) by rocking at 47 for 2 hr. The beads
each sample were chosen and photographed. The total were washed three times with lysis solution containing
number of viral particles was counted and reported as 0.1% SDS and were resuspended in 500 ml of lysis solu-
mean { SD. Statistical significance was determined us- tion containing 0.1% SDS. After immunoprecipitation at
ing the Student T test. 47 overnight, the supernatants were discarded and the
beads were washed four times with alternating high- and
Blockade of BgpA receptor
low-salt solutions (lysis solution containing 0.1% SDS and
either a 1 M or 150 mM NaCl). After rinsing, the proteinsBlockade experiments were performed as previously
described with monoclonal antibody (mAb) CC1 which were denatured at 1007 for 4 min in Laemmli loading
buffer and separated by electrophoresis on SDS–10%specifically binds to the N-terminus of BgpA (Chen and
Baric, 1996; Dveksler et al., 1993b; Williams et al., 1990). polyacrylamide gels. The gels were fixed in a 5% metha-
nol and 7% acetic acid solution for 30 min and thenThe CC1 mAb was collected from hybridoma culture su-
pernatants kindly provided by Dr. Kathryn V. Holmes (Uni- soaked overnight in a 10% acetic acid and 1.7% glycerol
solution. The gels were impregnated with Enlighteningversity of Colorado Health Sciences Center). Briefly, dif-
ferent cell clones were seeded at densities of 2 1 105 (Amersham), dried, and exposed to Kodak X-ray film at
0707. Gels were scanned with an AMBIS radioanalyticalcells per well in 24-well plates and incubated with 200
ml of a 1:4 dilution of mAb CC1 for 1 hr at 377. Alterna- imaging system (AMBIS, RIS) for 12 hr and individual
protein bands were imaged and quantitated.tively, 5.0 1 104 cells in 8-well LabTek chambers were
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RESULTS Monoclonal antibody CC1 blockade enhances virus
infection
Isolation of overexpressing BgpA cell clones
In cell lines expressing normal levels of receptor, mAb
CC1 pretreatment blocks MHV infection by binding BgpATo study the consequences of receptor expression on
and preventing entry (Dveksler et al., 1993; Williams etMHV replication, a cell clone (PDBT-5) was isolated at 30
al., 1990). The effect of mAB CC1 blockade on MHV-A59days postinfection. By FACs analysis, the PDBT-5 clone
entry and replication in cell lines expressing high levelsexpressed little BgpA receptor (0.26 mean fluorescence
of BgpA receptor has not been evaluated. Therefore, cellsafter removal of background staining) and was very resis-
were pretreated with mAb CC1 for 1 hr and infectedtant to wild-type MHV-A59 infection (Fig. 1a) (Chen and
with MHV-A59 at an m.o.i. of 5. Consistent with previousBaric, 1995, 1996). Following Bgp1a transfection into
findings, MHV-A59 replication was completely blockedPDBT-5 cells, we isolated several G-418 resistant cell
by CC1 pretreatment in both the DBT 9 and the R-14 cellclones (designated R-1 to R-24) and BgpA expression
clones which expressed normal levels of BgpA receptorwas quantified by FACs analysis. Mean levels of BgpA
(Fig. 3A) (Chen and Baric, 1996). Under identical treat-fluorescence in the R-14 clone were about 5.0 after re-
ment conditions, CC1 pretreatment completely reversedmoval of background staining (Fig. 1a). This compares
the block in MHV-A59 replication and increased virusfavorably with mean levels of BgpA expression (8.6)
titers by 3–4 logs in the BgpA-overexpressing R-17 clonenoted in the DBT-9 clone isolated from our uninfected
(Fig. 3B). Similar findings were also seen in the otherlaboratory stock of DBT cells (Fig. 1a) (Chen and Baric,
BgpA high-expressing clones (Fig. 3C). These effects1996). Interestingly, several G-418 resistant clones (R-2,
were specific as monoclonal antibodies (Col-1, EDDA)R-17, R-19, R-24) expressed extremely high levels of
directed against irrelevant antigens did not enhance vi-BgpA with mean fluorescence levels ranging from 134.6
rus replication in R-17 cells and serial twofold dilutionsto 429.4. After removal of background, this represented
of CC1 had progressively reduced capacities to reversean approximate 20- to 69-fold increase in BgpA expres-
the BgpA overexpression blockade (Figs. 4 and 5). Tosion compared to the wild-type DBT 9 clone (Figs. 1a
determine the time course of reversal, CC1 was addedand 1b).
prior to or at different times postinfection. Addition of CC1
antibodies through the first 6 hr postinfection resulted in
Overexpression of BgpA inhibits MHV-A59 replication significant reversal of the BgpA overexpression blockade
(Table 1).To study whether differing levels of viral receptor ex-
The growth of two variant viruses, V10 and V16/, iso-pression could alter MHV-A59 infection, virus replication
lated from MHV-A59-persistently infected DBT cultureswas studied in DBT-9, PDBT-5, and R-14, as well as in
at 119 days postinfection, were also studied since thesethe BgpA-overexpressing R-17 clone, which had a mean
viruses replicated to titers 1–2 logs higher than MHV-fluorescence of 429.4. MHV-A59 replication in the resis-
A59 and they recognized BgpA as well as other receptorstant PDBT-5 clone was extremely inefficient and little if
for entry into DBT cells (Chen and Baric, 1995, 1996).any syncytium formation was observed throughout infec-
Consonant with their increased replication capacities intion (Chen and Baric, 1996). This reduction was caused
DBT cell lines (Chen and Baric, 1996), V10 and V16/by the lack of available receptor for entry since MHV-
replicated more efficiently than MHV-A59 in the BgpA-A59 replication was extremely efficient in both the DBT-
overexpressing R-17 cells. Pretreatment with mAB CC19 clone and the R-14 clone which expressed wild-type
also increased variant virus titers by about 2–3 logs (Ta-levels of BgpA receptor. In these cell lines, infection was
ble 2). Similar increases in virus replication were alsocharacterized by extensive syncytium formation (Fig. 2).
observed in the other BgpA-overexpressing cell clonesMHV-A59 infection also caused extensive syncytium for-
(data not shown). An unrelated virus, Sindbis virus, repli-mation in the BgpA-overexpressing R-17 cell clone (Fig.
cated efficiently in the DBT 9, PDBT-5, and R-17 clones,2A). MHV-A59 titers in the R-17 cells, however, were
demonstrating the specificity of the BgpA overexpressionextremely low, similar to those in the highly resistant
receptor blockade for MHV-A59 (Table 3).parental PDBT-5 cell clone (Fig. 2B). To determine if the
reduction in MHV-A59 replication was associated with BgpA blockade occurs after virus transcription
overexpression of BgpA receptor, three additional
clones, R-2, R-19, and R-24 which displayed BgpA mean BgpA overexpression blockade likely occurred late in
virus infection since significant amounts of syncytiumfluorescence levels of 135.0, 279.0, and 341.0, respec-
tively, were also infected with MHV-A59. MHV-A59 repli- formation were observed in all overexpressing cell
clones. MHV-A59-induced fusion from without, however,cation in all BgpA-overexpressing clones resulted in ex-
tensive syncytium formation, yet virus titers were reduced could also account for these findings. Consequently, vari-
ous cell clones were infected with MHV-A59 and intracel-significantly by at least 3 to 4 logs (Fig. 2C).
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FIG. 1. Expression of BgpA in DBT cell clones was assessed by FACs analysis. a: DBT-9 (A), PDBT-5 (B), R-14 (C), and R-17 (D). b: R-2 (A), R-19
(B), and R-24 (C).
lular RNA harvested at different times postinfection. of viral transcription were evident in cell clones express-
ing normal BgpA levels (R-14, DBT-9) as well as in theEquivalent amounts of RNA were bound to nitrocellulose
filters and hybridized with a MHV-A59 N gene probe BgpA-overexpressing cell clone R-17. Levels of viral RNA
were higher in the R-17 cell clone at early times and(Schaad et al., 1990). As previously reported, little viral
RNA was detected in the highly resistant PDBT-5 cells nearly identical with the DBT 9 cells at later times postin-
fection (Fig. 6).(Chen and Baric, 1996). In contrast, significant amounts
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FIG. 2. BgpA overexpression blocks MHV-A59 replication. Syncytium formation in DBT-9 and R-17 cell lines following infection with MHV-A59 at
an m.o.i. of 5. (A) DBT-9 cell lines (a), R-17 cell lines (b). (B) MHV-A59 replication in DBT-9, PDBT-5, and R-14, as well as in the BgpA-overexpressing
R-17 cell lines. (C) MHV-A59 replication in the BgpA-overexpressing R-2, R-19, and R-24 cell lines.
To determine if levels of viral structural protein synthe- BgpA overexpression does not block virus release
sis were altered by the BgpA overexpression blockade,
The BgpA overexpression blockade may inhibit viruscultures of cells were fixed and FA was performed with a
assembly, maturation, and egress or establish an intra-polyclonal MHV-A59 antiserum. Since 95% of the cells
cellular trap which prevents infectious virus particleswere infected, near uniform amounts of fluorescence
from escaping the cell. Although we are aware of nowere observed throughout these cultures. Overall levels
precedents, BgpA overexpression may also coat virusof viral structural protein expression were measured by
particles with receptor during release and neutralize theirfluorescence density scanning across several fields and
infectivity. To distinguish among these possibilities, cul-were nearly identical in DBT 9, R-14, and the BgpA-over-
expressing R-17 clone (P  0.1) (data not shown). tures of cells were infected with MHV-A59 at an m.o.i. of
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FIG. 3. BgpA blockade is reversed by pretreatment with anti-receptor monoclonal antibody. Cultures of cells were pretreated for 1 hr with
monoclonal antibody CC1 which recognizes the N-terminal domain of BgpA. The antibodies were removed and the cultures infected with MHV-A59
at an m.o.i. of 5 for 1 hr. Virus titers were determined by plaque assay at the indicated times. (A) CC1 blockade of MHV-A59 replication in DBT-9
cell lines. (B) CC1 blockade of MHV-A59 replication in the BgpA-overexpressing R-17 cell line. (C) CC1 blockade of MHV-A59 replication in the
BgpA-overexpressing R-24 cell line.
5 for 1 hr. At different times postinfection the medium but not the DBT-9 cells, were incomplete and lacked
peplomer spike glycoproteins (Fig. 9).was removed and the cultures were extensively washed
with ice-cold PBS to remove extracellular virions. Intra-
BgpA overexpression reduces spike concentrations incellular virus was harvested from different infected cell
progeny virionsclones by freeze–thawing. Although intracellular titers of
MHV-A59 were extremely high in the control cell lines If high intracellular concentrations of BgpA resulted in
(DBT-9 and R-14), no significant accumulations of infec- an intracellular trap which sequestered the S glycopro-
tious virus were evidenced in the BgpA-overexpressing tein and prevented its incorporation into virions during
R-17 clone (Fig. 7). Although virus titers were slightly maturation, then progeny virions should contain less S
higher, similar findings were noted in other BgpA-overex- glycoprotein. To address this question, cultures of cells
pressing cell clones which expressed lower levels of were infected with MHV-A59, radiolabeled with [35S]-
BgpA (Fig. 7b). methionine and [35S]cysteine, and extracellular virions
Electron microscopic examination of the BgpA-overex- were concentrated by ultracentrifugation. The viral struc-
pressing cell lines revealed that intracellular virus parti- tural proteins S (gp180/90), N (pp 50), and M (gp 21) were
cles were not accumulating in internal or surface mem- clearly detected in the virions released from DBT 9 cells.
branes. Rather, virus-induced morphological changes Importantly, significant reductions in the amount of S
were similar (Oshiro, 1973), and cells that overexpressed glycoprotein, but not M or N, were evident in virions
BgpA had similar numbers of virions on the plasma mem- concentrated from the BgpA-overexpressing R-17 clone
brane as controls. In fact, significant numbers of virus (Fig. 10).
particles had been released from both the receptor-over- To determine the extent of S glycoprotein protein re-
expressing clones and the controls (data not shown). To duction, the quantity of each structural protein was deter-
determine whether equivalent numbers of particles were mined by AMBIS scans relative to M protein concentra-
released following infection, we concentrated the extra- tion in virions from DBT-9 cells (Table 4). While equivalent
cellular virions from infected DBT 9 and R-17 cell culture amounts of N and M were present in virions released
medium by ultracentrifugation and counted the number from both DBT-9 and R-17 BgpA-overexpressing cell
of virus particles by negative staining. While the number lines, virions from R-17 cells contained an 70% reduc-
of infectious particles from the BgpA-overexpressing R- tion in the amount of S glycoprotein. These data clearly
17 cells were reduced by 4 logs by plaque assay (Fig. suggested that the BgpA overexpression blockade did
8A), the number of extracellular particles was roughly not affect virus egress, but rather, trapped the S glycopro-
equivalent with the DBT 9 control (Fig. 8B). These data tein within intracellular compartments and resulted in the
suggested that BgpA overexpression did not block virus formation and release of noninfectious particles.
egress, yet most particles were noninfectious. As the
infectivity of virions derived from R-17 cells could not DISCUSSION
be restored by CC1 treatment (Fig. 8A), these findings
suggested that the progeny virions were not coated with Coronavirus infections cause severe economic losses
in the poultry and swine industry and are responsible forBgpA. Rather, ultrastructural studies suggested that viri-
ons derived from the BgpA-overexpressing R-17 clone, about 20–30% of the common colds in humans. While
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FIG. 4. Specificity of CC1 reversal of the BgpA blockade. Cultures of DBT-9 or R-17 cells were treated with monoclonal antibodies CC1 or with
antibodies (EDDA, Col-1) which were directed against irrelevant antigens. After pretreatment for 1 hr, the antibodies were removed and the cultures
infected with MHV-A59 at an m.o.i. of 5. Samples were taken at the indicated times and assayed by plaque assay. (A) Virus replication in DBT-9
cells. (B) Virus replication in R-17 cells.
vaccines have provided some level of protection in ani- for virus entry represents a reasonable approach to en-
hance intracellular resistance against coronavirus infec-mals, the extreme antigenic variability noted among in-
fectious bronchitis viruses and human coronaviruses tions.
Biliary glycoproteins have been shown to be homo-have demonstrated that newer methods are needed to
block the pathogenic potential of these viruses (Enjuanes philic cell adhesion proteins that bind calmodulin, have
ectoATPase activity, function in taurocholate transport,et al., 1995). The results presented in this paper confirm
and expand upon earlier findings by Gallagher (1995) and may function like tumor suppresser genes in vitro
(Hseih et al., 1995; Lin and Gudotti, 1989; Rosenberg etand suggest that gene therapy using host receptor genes
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FIG. 5. CC1 concentration and reversal of the BgpA overexpression blockade. Cultures of R-17 cells were treated with twofold serial dilutions of
mAB CC1 for 1 hr. After MHV-A59 infection for 1 hr, complete medium containing CC1 was added to each well, and samples were taken at the
indicated times for plaque assay. (A) Cultures of R-17 cells treated with twofold serial dilutions of CC1, or monoclonal antibodies EDDA and Col-
1. (B) The effect of CC1 concentration and reversal of the BgpA overexpression blockade at 20 hr postinfection in R-17 cells. On the x-axis E denotes
EDDA-treated cells and C denotes Col-1-treated cells.
al., 1993). In mice, Bgp expression is mainly localized in BgpA overexpression effectively blocked the release of
infectious virus, suggesting that tissues or cells express-the liver and intestinal brush border. Only the two domain
isoform of Bgp1a (MHVR2) is weakly expressed in the ing low levels of receptor may represent better targets
for efficient MHV replication. It has been suggested thatbrain (Williams et al., 1990; Yokomori and Lai, 1992). In
this study, BgpA overexpression did not result in abnor- alternative receptor utilization may mediate the pro-
nounced CNS neurotropism of some MHV strains sincemal DBT cell morphology or growth rates in vitro. Rather,
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TABLE 1 TABLE 3
Time Course of MAB CC1 Blockade on MHV-A59 Replication Replication of Sindbis Virus in DBT-9 and the
BgpA-Overexpressing R-17 Clonein R-17 Cells
Virus titers (PFU/ml) Virus titers
mAb CC1
Cell line 12 hr 24 hrTreatment 0 hr PI 24 hr PI
None 1.5 1 103 8.4 1 104 DBT-9 1.7 1 107 1.0 1 108
R-17 1.5 1 106 1.3 1 1071 hr pretreatment 4.0 1 103 1.4 1 107
0 hr postinfection 1.5 1 103 3.4 1 107
3 hr postinfection 1.5 1 103 4.0 1 107
6 hr postinfection 1.5 1 103 2.2 1 107
since overexpression of truncated BgpA forms lacking
these critical virus binding residues did not significantly
inhibit virus replication (Gallagher, 1995), and CC1 rever-Bgp1 expression in these tissues is quite low (Chen et
sal was likely mediated by binding residues that map inal., 1995; Yokomori and Lai, 1992). Our data, however,
the N terminus of BgpA (Dveksler et al., 1993). While wesuggest that low receptor expression may not only be
noted an approximate 70% reduction in both the unclea-sufficient, but preferred by neutrotropic strains of MHV
ved and the cleaved forms of S in extracellular virions,if these variants display increased affinity or avidity for
further studies are needed to determine if the S1 domainthe Bgp1 receptor.
is preferentially stripped from progeny virions (Kubo etCoronaviruses bud between the rough endoplasmic
al., 1994; Suzuki and Taguchi, 1996). In an analogousreticulum (RER) and the Golgi apparatus in an intermedi-
system, the extreme overexpression of BgpA in vacciniaate compartment in the cell and particles are then trans-
viruses almost completely abrogated the incorporationported in vesicles via the constitutive exocytic pathway
of S into extracellular virions (Gallagher, 1995). The differ-to the surface of the cell (Griffiths and Rottier, 1992; Tooze
ences in virion spike accumulation in the two systemset al., 1984; Tooze and Tooze, 1985). In contrast to most
likely reflects levels of BgpA expression in the host cell.viruses, envelope formation in coronaviruses is not de-
Although additional studies are needed, possible mecha-pendent upon the budding of nucleocapsids and only the
nisms for BgpA blockade include the inhibition of properM and E glycoproteins are required for particle formation.
S glycoprotein folding, cleavage, and transport, or by se-The S glycoprotein spike is also dispensable but, if pres-
questering of S in receptor–ligand complexes that can-ent, is efficiently incorporated into particles (Vennema et
not participate in assembly.al., 1996). In agreement with these findings, tunicamycin-
The observations that receptor overexpression maytreated cells release noninfectious particles that contain
inhibit virus replication and antireceptor antibodies maynormal amounts of the M and N structural proteins, but
enhance virus replication underscore the complexity oflittle S glycoprotein (Holmes et al., 1991), and mutants
containing S gene ts alleles produce noninfectious parti-
cles that lack S (Richard et al., 1995). Our results are
entirely consistent with the observation that S is not criti-
cal for coronavirus particle formation.
In this study, overexpression of BgpA likely saturated
the RER, Golgi, and surface membranes, effectively pro-
ducing an intracellular trap that prevented the incorpora-
tion of S glycoprotein into virions. Blockade is likely medi-
ated by S binding residues at the N-terminus of BgpA
TABLE 2
Replication of Variant Viruses Following CC1 Pretreatment
Virus CC1 treatment Virus titer (12 hr)
V1 0 8.3 1 104
V1 / 6.8 1 106
FIG. 6. Virus transcription in BgpA-overexpressing clones. CulturesV16 0 1.1 1 105
of cells were infected with MHV-A59 at an m.o.i. of 5 and intracellularV16 / 1.2 1 107
RNA was isolated at the indicated times. The RNA was bound to nitro-A59 0 6.8 1 103
cellulose filters and hybridized with an MHV-A59 N gene-specific probe.A59 / 1.4 1 107
CPM were quantified by AMBIS RIS.
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FIG. 7. Intracellular titers of MHV-A59 following BgpA blockade. Cultures of cells were infected with MHV-A59 at an m.o.i. of 5. At the indicated
times, the cultures were extensively washed with PBS to remove extracellular virions, and the cells were lysed and titered by plaque assay in DBT cells.
(A) MHV-A59 replication in DBT-9, R-14, and the BgpA-overexpressing R-17 clone. (B) MHV-A59 replication in DBT-9, and the BgpA-overexpressing R-
24, R-19, and R-2 clones.
virus–receptor interactions. In cell lines overexpressing ration of S into progeny virions (Cerneus et al., 1993;
Chaplin and Matlin, 1989; Hubbard et al., 1989). In sup-BgpA, the concentration of CC1 available in hybridoma
supernatants was probably insufficient to complex all port of this hypothesis, addition of virus-specific IgG
monoclonal antibodies enhanced clearance of Sindbisavailable receptor and block virus entry, yet was suffi-
ciently high to reduce the intracellular bioavailability of virus infection in neurons (Levine et al., 1991), and IgA-
mediated mucosal immunity in the gut likely occurs viathe BgpA receptor protein. CC1 binding to receptors in
the plasma membrane might directly reduce the intracel- intracellular neutralization of virus within the enterocyte
(Burns et al., 1996; Kaetzel et al., 1991; Mazanec et al.,lular concentration of the BgpA receptor; however, this
mechanism seems unlikely since CC1 reversal could oc- 1992, 1995).
Our findings are analogous to studies demonstratingcur as late as 6 hr postinfection. Rather, CC1 monoclonal
antibodies complexed with BgpA were probably endocy- that overexpression of the CD4 receptor blocked HIV
replication in vitro. In this system, CD4 targeted to RERtosed and transported directly into intracellular compart-
ments. This likely altered the intracellular milieu and bio- membranes effectively trapped the HIV gp160 glycopro-
tein and prevented virus spread, syncytium formation,availability of BgpA, thereby permitting efficient incorpo-
FIG. 8. Particle counts following MHV-A59 infection. Cultures of cells were infected with MHV-A59 at an m.o.i. of 5. The supernatants were
clarified by centrifugation, and the particles were concentrated by ultracentrifugation through sucrose gradients. Concentrated viruses were titered
by plaque assay and equal volumes were examined by negative straining in the electron microscope. (A) Plaque-forming units after monoclonal
antibody CC1 treatment of purified virions preparations from DBT-9 and the BgpA-overexpressing R-17 clone. (B) Particle counts following negative
straining.
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FIG. 9. Ultrastructural evaluation of MHV virions. Purified virions were subjected to negative straining and examined under an electron microscope.
(A and B) MHV-A59 isolated from DBT-9 cells. (C and D) MHV-A59 isolated from the BgpA-overexpressing R-17 clone. Dark arrows indicate peplomer
spike glycoproteins and white arrowheads denote virus particles devoid of spikes.
and the production of progeny virions (Bunocore and
Rose, 1990, 1993). It seems likely that specific targeting
of BgpA expression into internal membranes might also
reduce MHV-induced syncytium formation and cell death
as well. Since MHV may also use other receptors for
entry (Bgp1b, Bgp2, and brain CEA) (Dveksler et al., 1993;
Chen et al., 1995; Nedellec et al., 1994), overexpression
of these alternative receptors may also mediate a domi-
nant negative phenotype on MHV replication. Intracellu-
lar immunization with the porcine coronavirus aminopep-
tidase N receptor also appears to prevent efficient TGEV
replication in vitro, predicting that this strategy will prove
effective against most coronaviruses (Delmas et al.,
1992, 1995). Virus–receptor interactions are critical
events in initiating infection. Consequently, this approach
may prove successful at ablating the replication and pa-
thogeneic potential of most viruses in plants and animals.
It should be noted, however, that a threefold overex-
pression of the Sindbis laminin receptor increased virus
binding and infectivity in vitro (Wang et al., 1992).
Gene therapy holds great promise in ablating theFIG. 10. Viral protein concentrations in purified virions. Cultures of
cells were infected with MHV-A59 and radiolabeled with [35S]- pathogenic potential of viruses in humans, animals, and
methionine and [35S]cysteine as described under Materials and Meth- plants (Baltimore, 1988; Fitchen and Beachy, 1993; Olson
ods. The virions were purified through sucrose gradients, bound to et al., 1996). Although intracellular immunization using
polyclonal antiserum against MHV, and immunoprecipitated. The viral
host-derived factors has received less attention, virusproteins were separated on 8% polyacrylamide gels. Lane 1, virion
replication is clearly dependent upon efficient interac-proteins from DBT-9 cells. Lane 2, virion proteins from the BgpA-overex-
pressing R-17 cells. tions between specific viral and cellular genes, providing
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TABLE 4
Relative Ratio of MHV-A59 Structural Proteins in Virions from DBT-9 and R-17 Cells
CPM in virion proteins CPM standardized to N
Structural Ratio
proteins DBT 9 R-17 DBT 9 R-17 (R-17/DBT-9)
M 505 881 848 881 1.04
N 1069 1800 1796 1800 1.00
S 2851 1337 4789 1337 0.28
S (180) 1901 1225 3194 1225 0.38
Boyle, J. F., Weismiller, D. G., and Holmes, K. V. (1987). Genetic resis-a potentially rich source of genetic targets for disrupting
tance to mouse hepatitis virus correlates with absence of virus-virus replication at the cellular level. Host genes that
binding activity on target tissues. J. Virol. 61, 185–189.
function in RNA virus replication include cellular recep- Buonocore, L., and Rose, J. K. (1993). Blockade of human immunodefi-
tors (Weiss, 1993; Yeager et al., 1992; Delamas et al., ciency virus type 1 production in CD4/ cells by an intracellular CD4
1995; Wang et al., 1992) and other host factors that func- expressed under control of the viral long terminal repeat. Proc. Natl.
Acad. Sci. USA 90, 2695–2699.tion in entry (Asanaka and Lai, 1993; Feng et al., 1996;
Buonocore, L., and Rose, J. K. (1990). Prevention of HIV-1 glycoproteinSiess et al., 1996; Yokomori and Lai, 1993). Host factors
transport by soluble CD4 retained in the endoplasmic reticulum.also function in the transcription of many positive-strand
Nature 345, 625–628.
RNA viruses (Andrews and Baltimore, 1986; Baric et al., Burns, J. W., Siadat-Pajouh, M., Krishnaney, A. A., and Greenberg, H. B.
1982; Zhang and Lai, 1995b), and cellular proteins bind to (1996). Protective effect of rotavirus VP6-specific IgA monoclonal
antibodies that lack neutralizing activity. Science 272, 104–107.viral positive- and negative-stranded RNAs in vitro (Zhang
Chaplan, M., and Matlin, K. S. (1989). Sorting of membrane and secre-and Lai, 1995). Identification of host alleles that govern
tory proteins in polarized epithelial cells. In ‘‘Functional Epithelialsusceptibility and resistance to viral infection may also
Cells in Culture’’ (K. S. Matlin and J. D. Valentich, Eds.), pp. 71–127.
provide additional targets for gene therapy as well (Malo A. R. Liss, New York.
and Skamene, 1994; Pavlovic et al., 1992; Buschman and Cerneus, D. P., Strous, G. J., and Van der Ende, A. (1993). Bidirectional
transcytosis determines the steady state distribution of the trans-Skamene, 1995). It remains to be determined, however,
ferrin receptor at opposite plasma membrane domains of BeWo cells.whether intracellular immunization will prove an effective
J. Cell Biol. 122, 1233–1230.means of preventing disease or whether this approach
Chen, D. S., Asanaka, M., Yokomori, K., Wang, F-I., Hwang, S. B., Li,will promote an evolutionary arms race between geneti- H-P., and Lai, M. M. C. (1995). Pregnancy-specific glycoprotein is
cally engineered host defense mechanisms and in- expressed in the brain and serves as a receptor for mouse hepatitis
creased virus virulence and pathogenesis (Chen and virus. Proc. Natl. Acad. Sci. USA 92, 12095–12099.
Chen, W., and Baric, R. S. (1995). Function of a 5*-end genomic RNABaric, 1996; Dawkins and Krebs, 1979; McKeating et al.,
mutation that evolves during persistent mouse hepatitis virus infec-1991).
tion in vitro. J. Virol. 69, 7529–7540.
Chen, W., and Baric, R. S. (1996). Molecular anatomy of mouse hepatitis
ACKNOWLEDGMENTS virus persistence: Coevolution of increased host cell resistance and
virus virulence. J. Virol. 70, 3947–3960.We thank Sheila Peel, Boyd Young Jr., Lisa Hensley, and Erlina Sira-
Compton, S. R. (1994). Enterotropic strains of mouse coronavirus differqusa for excellent technical assistance and for checking the manu-
in their use of murine carcinoembryonic antigen-related glycoproteinscript. This study was supported by a research grant from National
receptors. Virology 203, 197–201.Institutes of Health (AI 23964) and a fellowship to W.C. from the Public
Dawkins, R., and Krebs, J. R. (1979). Arms races between and withinHealth Service (5 T32 A107151-16).
species. Proc. R. Soc. London Ser. B 205, 489–511.
Delmas, B., Gelfi, J., L’Haridon, R., Vogel, L. K., Sjostrom, H., Noren, O.,REFERENCES and Laude, H. (1992). Aminopeptidase N is a major receptor for the
enteropathogenic coronavirus TGEV. Nature (London) 357, 417–420.Andrews, N. C., and Baltimore, D. (1986). Purification of a terminal uridy-
Delmas, B., Kut, E., Gelfi, J., and Laude, H. (1995). Overexpression oflytransferase that acts as a host factor for the in vitro poliovirus
TGEV cell receptor impairs the production of virus particles. Adv.replicase reaction. Proc. Natl. Acad. Sci. USA 83, 221–225.
Exp. Med. Biol. 380, 379–385.Asanaka, M., and Lai, M. M. C. (1993). Cell fusion studies identified
Dveksler, G. S., Basile, A. A., Cardellichio, C. B., and Holmes, K. V.multiple cellular factors involved in mouse hepatitis virus entry. Virol-
(1995). Mouse hepatitis virus receptor activities of an MHVR/mphogy 197, 732–741.
chimera and MHVR mutants lacking N-linked glycosylation of the N-Baltimore, D. (1988). Intracellular immunization. Nature 335, 395–396.
terminal domain. J. Virol. 69, 543–546.Baric, R. S., Lineberger, D. W., and Johnston, R. E. (1982). Reduced syn-
thesis of sindbis negative strand RNA in cultures treated with host Dveksler, G. S., Dieffenbach, C. W., Cardellichio, C. B., McCuaig, K.,
Pensiero, M. N., Jiang, G.-S., Beauchemin, N., and Holmes, K. V.transcription inhibitors. J. Virol. 47, 46–54.
Baric, R. S., Fu, K. S., Schaad, M. M. C., and Stohlman, S. A. (1990). (1993). Several members of the mouse carcinoembryonic antigen-
related glycoprotein family are functional receptors for the coronavi-Establishing a genetic recombination map of MHV-A59 complemen-
tation groups. Virology 177, 646–656. rus mouse hepatitis virus-A59. J. Virol. 67, 1–8.
AID VY 8402 / 6a29$$$$44 02-05-97 11:03:35 viras AP: Virology
331INTRACELLULAR IMMUNIZATION AGAINST MHV
Dveksler, G. S., Pensiero, M. N., Cardellichio, C. B., Williams, R. K., Ji- and Griffin, D. E. (1991). Antibody-mediated clearance of alphavirus
infection from neurons. Science 254, 856–860.ang, G.-S., Holmes, K. V., and Dieffenbach, C. W. (1991). Cloning of
the mouse hepatitis virus (MHV) receptor: expression in human and Lin, S-H., and Gudotti, G. (1989). Cloning and expression of a cDNA
coding for a rat liver plasma membrane ecto-ATPase. J. Biol. Chem.hamster cell lines confers susceptibility to MHV. J. Virol. 65, 6881–
6891. 264, 14408–14414.
Locker, J. K., Rose, J. K., Horzinek, M. C., and Rottier, P. J. (1992). Mem-Dveksler, G. S., Pensiero, M. N., Dieffenbach, C. W., Cardellichio, C. B.,
Basile, A. A., Ella, P. E., and Holmes, K. V. (1993). Mouse hepatitis brane assembly of the triple-spanning coronavirus M protein. Individ-
ual transmembrane domains show preferred orientation. J. Biol.virus strain A59 and blocking antireceptor monoclonal antibody bind
to the N-terminal domain of cellular receptor. Proc. Natl. Acad. Sci. Chem. 267, 21911–21918.
Luytjes, W., Bredenbeek, P. J., Noten, A. F. H., Horzinek, M. C., andUSA 90, 1716–1720.
Enjuanes, L., Smerdou, C., Castilla, J., Anton, I. M., Torres, J. M., Sola, Spaan, W. J. M. (1987). Sequence of mouse hepatitis virus A59
mRNA2: Indications for RNA recombination between coronavirus andI., Golvano, J., Sanchez, J. M., and Pintado, B. (1995). Development
of protection against coronavirus induced diseases. Adv. Exp. Med. influenza C virus. Virology 166, 415–422.
Malo, D., and Skamene, E. (1994). Genetic control of host resistanceBiol. 380, 197–211.
Feng, Y., Broder, C. C., Kennedy, P. E., and Berger, E. A. (1996). HIV-1 to infection. Trends Genet. 10, 365–371.
Mazanec, M. B., and Kaetzel, C. S. (1992). Intracellular neutralization ofentry cofactor: Functional cDNA cloning of a seven transmembrane,
G protein-coupled receptor. Science 272, 872–877. virus by immunoglobulin A antibodies. Proc. Natl. Acad. Sci. USA 89,
6901.Fitchen, J. H., and Beachy, R. N. (1993). Genetically engineered protec-
tion against viruses in transgenic plants. Annu. Rev. Microbiol. 47, Mazanec, M. B., Coudret, C. L., and Fletcher, D. R. (1995). Intracellular
neutralization of influenza virus by immunoglobulin A antihemaggluti-739–763.
Friedman, A. D., Triezenberg, S. J., and McKnight, S. L. (1988). Expres- nin monoclonal antibodies. J. Virol. 69, 1339.
McCuaig, K., Rosenberg, M., Nedellec, P., Turbide, C., and Beauchemin,sion of a truncated viral trans-activator selectively impedes lytic infec-
tion by its cognate virus. Nature (London) 335, 452–454. N. (1993). Expression of the Bgp gene and characterization of mouse
colon biliary glycoprotein isoforms. Gene 127, 173–183.Gallagher, T. M. (1995). Overexpression of the MHV receptor: effect on
progeny virus secretion. Adv. Exp. Med. Biol. 380, 331–336. McKeating, J. A., Balfe, P., Clapham, P. R., and Weiss, R. A. (1991). Re-
combinant soluble CD4 selected HIV-1 variants with reduced envGraves, P. J., Olson, K. E., Higgs, S., Powers, A. M., Beaty, B. J., and
Blair, C. D. (1996). Pathogen-derived resistance to Dengue type 2 affinity for CD4 and increased cell fusion ability. J. Virol. 65, 4777–
4785.virus in mosquito cells by expression of the premembrane coding
region of the viral genome. J. Virol. 70, 2132–2137. Nedellec, P., Dveksler, G. S., Daniels, E., Turbide, C., Chow, B., Basile,
A. A., Holmes, K. V., and Beauchemin, N. (1994). Bgp2, a new memberGriffiths, G., and Rottier, P. (1992). Cell biology of viruses that assemble
along the biosynthetic pathway. Semin. Cell Biol. 3, 367–381. of the carcinoembryonic antigen-related gene family, encodes an
alternative receptor for mouse hepatitis viruses. J. Virol. 68, 4525–Hirano, N., Fujiwara, K., Hino, S., and Matumoto, M. (1974). Replication
and plaque formation of mouse hepatitis virus (MHV-2) in mouse 4537.
Olson, K. E., Higgs, S., Gaines, P. J., Powers, A. M., Davis, B. S., Kamrud,cell line DBT culture. Arch. Gesamte Virusforsch. 44, 298–302.
Holmes, K. V., Doller, E. W., and Sturman, L. S. (1981). Tunicamycin K. I., Carlson, J. O., Blair, C. D., and Beaty, B. J. (1996). Genetically
engineered resistance to Dengue 2 virus transmission in mosqui-resistant glycoprotein of coronavirus glycoprotein: Demonstration of
a novel type of viral glycoprotein. Virology 115, 334–344. toes. Science 272, 884–886.
Oshiro, L. S. (1973). Coronaviruses. In ‘‘Ultrastructure of Animal VirusesHseih, J-T., Luo, W., Song, W., Wang, Y., Kleinerman, D. I., Van, N. T., and
Lin, S-H. (1995). Tumor suppressive role of an androgen-regulated and Bacteriophages: An Atlas’’ (A. J. F. Dalton and Haguenau, Eds.),
pp. 331–343. Academic Press, New York.epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell
revealed by sense and antisense approaches. Cancer Res. 55, 190– Pachuk, C., Bredenbeek, P. J., Zoltick, P. W., Spaan, W. J. M., and Weiss,
S. R. (1989). Molecular cloning of the gene encoding the putative197.
Hubbard, A. L., Stieger, B., and Bartles, J. R. (1989). Biogenesis of en- polymerase of mouse hepatitis coronavirus, strain A59. Virology 171,
141–148.dogenous plasma membrane proteins in epithelial cells. Annu. Rev.
Physiol. 51, 555–570. Pavlovic, J., Haller, O., and Staeheli, P. (1992). Human and mouse Mx
proteins inhibit different steps of the influenza virus multiplicationKaetzel, C. S., Robinson, J. K., Chintalacharuvu, K. R., Vaerman, J.-P.,
and Lamm, M. E. (1991). The polymeric immunoglobulin receptor cycle. J. Virol. 66, 2564–2569.
Richard, C. S., Koetzner, C. A., Sturman, L. S., and Masters, P. S. (1995).mediates transport of immune complexes across epithelial cells: A
local defense function for IgA. Proc. Natl. Acad. Sci. USA 88, 8796– A conditional lethal murine coronavirus A59 ts mutant fails to incorpo-
rate the spike glycoprotein into assembled virions. Virus Res. 39,8800.
Kubo, H., Yamada, Y. K., and Taguchi, F. (1994). Localization of neutraliz- 261–276.
Rosenberg, M., Nedellec, P., Jothy, S. S., Fleiszer, D., Turbide, C., anding epitopes and the receptor binding site within the amino-terminal
330 amino acids of the murine coronavirus spike glycoprotein. J. Beauchemin, N. (1993). The expression of mouse biliary glycoprotein,
a carcinoembryonic antigen-related gene, is down-regulated in ma-Virol. 68, 5403–5410.
Kurilla, M. G., and Keene, J. D. (1983). The leader RNA of vesicular lignant mouse tissues. Cancer Res. 53, 4938–4945.
Sarver, N., Cantin, E. M., Chang, P. S., Zaia, J. A., Ladne, P. A., Stephens,stomatitis virus is bound by a cellular protein reactive with anti-La
lupus antibodies. Cell 34, 837–845. D. A., and Rossi, J. J. (1990). Ribozymes as potential anti-HIV-1 thera-
peutic agents. Science 247, 1222–1225.Lai, M. M. C. (1992). Coronaviruses: Organization, replication and ex-
pression of the genome. Annu. Rev. Microbiol. 44, 303–333. Schaad, M. M. C., Stohlman, S. A., Egbert, J., Lum, K., Wei, T., and Baric,
R. S. (1990). Genetics of MHV transcription: Identification of cistronsLevine, B., Huang, Q., Isaacs, J. T., Reed, J. C., Griffin, D. E., and Hard-
wick, J. M. (1993). Conversion of lytic to persistent alphavirus infec- which may function in positive and negative strand RNA synthesis.
Virology 196, 190–198.tion by the Bcl-2 oncogene. Nature 361, 739–742.
Levine, B., Goldman, J. E., Jiang, H. H., Griffin, D. E., and Hardwick, J. M. Shaheen, F., Duan, L., Zhu, M., Bagasra, O., and Pomerantz, R. J. (1996).
Targeting human immunodeficiency virus type 1 reverse transcriptase(1996). Bcl-2 protects mice against fatal alphavirus encephalitis. Proc.
Natl. Acad. Sci. USA 93, 4810 –4815. by intracellular expression of single-chain variable fragments to inhibit
early stages of the viral life cycle. J. Virol. 70, 3392–3400.Levine, B., Hardwick, J. M., Trapp, B. D., Crawford, T. O., Bollinger, R. C.,
AID VY 8402 / 6a29$$$$44 02-05-97 11:03:35 viras AP: Virology
332 CHEN ET AL.
Siess, D. C., Kozak, S. L., and Kabat, D. (1996). Exceptional fusiogenicity Weiss, R. A. (1993). Cellular receptors and viral glycoproteins involved
in retrovirus entry. In ‘‘The Retroviridae’’ (J. A. Levy, Ed.), pp. 1–108.of Chinese hamster ovary cells with murine retroviruses suggests
roles for cellular factor(s) and receptor clusters in the membrane Plenum, New York.
Williams, R. K., Jiang, G.-S., Snyder, S. W., Frana, M. F., and Holmes,fusion process. J. Virol. 70, 3432–3439.
Sturman, L., and Holmes, K. (1985). The novel glycoproteins of coronavi- K. V. (1990). Purification of the 110-kilodalton glycoprotein receptor
for mouse hepatitis virus (MHV)-A59 from mouse liver and identifica-ruses. Trends Biochem. Sci. 10, 17–20.
Suzuki, H., and Taguchi, F. (1996). Analysis of the receptor-binding site tion of a nonfunctional, homologous protein in MHV-resistant SJL/J
mice. J. Virol. 64, 3817–3823.of murine coronavirus spike glycoprotein. J. Virol. 70, 2632–2636.
Tooze, J., Tooze, S. A., and Warren, G. (1984). Replication of coronavirus Yeager, C. L., Ashmun, R. A., Williams, R. K., Cardellichio, C. B., Shapiro,
L. H., Look, A. T., and Holmes, K. V. (1992). Human aminopeptidaseMHV-A59 in sac- cells: Determination of the first site of budding of
progeny virions. Eur. J. Cell Biol. 33, 281–293. N is a receptor for human coronavirus 229E. Nature (London) 357,
420–422.Tooze, J., and Tooze, S. A. (1985). Infection of AtT20 murine pituitary
tumor cells by mouse hepatitis virus strain A59: Virus budding is Yokomori, K., Asanaka, M., Stohlman, S. A., and Lai, M. M. C. (1993). A
spike protein-dependent cellular factor other than the viral receptorrestricted to the golgi region. Eur. J. Cell Biol. 37, 303–312.
Ubol, S., Tucker, P. C., Griffin, D. E., and Hardwick, J. M. (1991). Neurovi- is required for mouse hepatitis virus entry. Virology 196, 45–56.
Yokomori, K., and Lai, M. M. C. (1992). Mouse hepatitis virus utilizesrulent strains of alphavirus induce apoptosis in Bcl-2 expressing
cells: Role of a single amino acid change in the E2 glycoprotein. two carcinoembryonic antigens as alternative receptors. J. Virol. 66,
6194–6199.Proc. Natl. Acad. Sci. USA 91, 5202–5296.
Vennema, H., Godeke, G-J., Rossen, J. W. A., Voorhout, W. F., Horzinek, Yu, X., Weiss, S. R., and Leibowitz, J. L. (1994). Mouse hepatitis gene
5b is a new virion envelope glycoprotein. Virology 202, 1018–1023.M. C., Opstelten, D-J., and Rottier, P. J. M. (1996). Nucleocapsid-inde-
pendent assembly of coronavirus-like particles by coexpression of Zhang, X. M., and Lai, M. M. C. (1995). Interactions between the cyto-
plasmic proteins and intergenic sequence of mouse hepatitis virusviral envelope protein genes. EMBO J. 15, 2020–2028.
Wang, K.-S., Kuhn, R. J., Strauss, E. G., Ou, S., and Strauss, J. H. (1992). RNA: Correlation with the amount of subgenomic mRNA transcribed.
J. Virol. 69, 1637–1644.High-affinity laminin receptor is a receptor for Sindbis virus in mam-
malian cells. J. Virol. 66, 4992 –5001. Zhang, X. M., and Lai, M. M. C. (1995b). Regulation of coronavirus RNA
transcription is likely mediated by protein–RNA interactions. Adv.Weber, J. (1990). Blocks on the viral exit. Nature (London) 345, 573–
574. Exp. Med. Biol. 380, 515–522.
AID VY 8402 / 6a29$$$$44 02-05-97 11:03:35 viras AP: Virology
